 |
Botulinum Toxin
Botulinum Toxin Dermax Online
Introduce a concise product overview explaining that Dermax supplies high-quality Botulinum Toxin Type A for licensed aesthetic clinics, distributors, and medical professionals. The product is available in 100U and 200U presentations and is commonly used for the temporary improvement of dynamic facial wrinkles and facial contouring procedures. With reliable manufacturing standards, competitive wholesale pricing, and global shipping support, Dermax provides a dependable sourcing solution for international aesthetic businesses.
Botulinum Toxin Online
When administered by qualified medical professionals, Botulinum Toxin Type A is commonly incorporated into aesthetic treatment plans for dynamic facial wrinkles and selected muscle-related indications.
Forehead Lines
Repeated contraction of the frontalis muscle may lead to horizontal forehead lines. Treatment can temporarily soften these expression lines while preserving natural facial movement when appropriately dosed.
Glabellar Lines
Vertical frown lines between the eyebrows are among the most frequently treated areas. Relaxing the corrugator and procerus muscles may reduce the appearance of moderate to severe glabellar lines.
Crow's Feet
Fine lines around the outer corners of the eyes develop through repeated smiling and facial expression. Treatment may improve their appearance while maintaining a natural-looking smile.
Bunny Lines
Wrinkles that form along the sides of the nose during facial expression can also be treated in selected patients.
Chin Appearance
Carefully placed injections may help reduce excessive contraction of the mentalis muscle, improving the appearance of chin dimpling.
Jawline Contouring
Injection into enlarged masseter muscles may gradually reduce muscle bulk in appropriate candidates, contributing to a slimmer lower facial contour.
Calf Muscle Contouring
For selected individuals with muscle-related calf enlargement, treatment may reduce muscle volume over time as part of a body contouring plan.
Botulinum Toxin Type A temporarily blocks the release of acetylcholine at the neuromuscular junction, reducing muscle contraction. As the treated muscles relax, dynamic facial wrinkles gradually soften while surrounding tissues maintain a natural appearance. Results typically become noticeable within several days and gradually diminish as normal nerve activity returns.
Proper storage helps maintain product quality before clinical use.
Store under refrigerated conditions between 2°C and 8°C.
Keep the vial in its original package until use.
Protect the product from excessive heat and direct sunlight.
Do not freeze unless specifically indicated by the manufacturer.
Use only before the labeled expiration date.
Reconstituted product should be handled according to the manufacturer's instructions and applicable clinical protocols.
Specifications Botulinum Toxin Filling
 | Volume | 100U | 200U |
| Complex Size | 900kDa | 900kDa | |
| Appearance | Freeze-dried | Freeze- dried | |
| Potency | KFDA/In-House 80-125/95-115 | KFDA/In-House 160-250/195-240 | |
| Protein(ng/vial) | <5 | <10 | |
| PH | 6.5+0.5 | 6.5+0.5 | |
| Moisture | Less than 3% | Less than 3% |
 | Volume | 100U | |
| Appearance | Freeze -dried | ||
| Composition | 100units of clostridium | ||
0.5mg of human serum alibumin | |||
| 0.9mg of sodium chloride | |||
Dilution Information | 6.5+0.5 Less than 3% | Restulting Dose Units (Units/0.1ml) | |
1.0ml 2.0ml 4.0ml 8.0ml | 10.0U 5.0U 2.5U 1.25U | ||
 | Volume | 100U | |
| Efficacy effects | Temporay improvement in the appearance of moderate to severe glabella wrinkles associated with corrugator musleand/or procerus muscle activities | ||
| Main ingredients | clostridium -100 units | ||
| Description | White or light yellow lyophilizate in a colorless transparent vial that becomes clear and transparent when dissolved in physiological saline | ||
| Classification | White or light yellow lyophilizate in a colorless transparent vial that becomes clear and transparent when dissolved in physiological saline | ||
| Storage | Sealed container,refrigerated(2~8"C)storage | ||
Application of Dermax Botulinum Toxin
Botulinum Toxin - Application
Botulinum Toxin - Application
Advantage of Botulinum Toxin
(1) Wrinkle surgery injected drugs will be absorbed by the body for several hours, no urgery, no pain, quick effect.
(2) Accurate biological wrinkle removal. Effect appears shortly. The product for wrinkle surgery using a small amount of biological agents for facial multi-point subcutaneous injection, short-term precise elimination of facial dense small wrinkles, such as forehead, eyebrows, extraocular ankle, cheek Wrinkles, mouth, neck and other, make the skin shiny and elastic.
(3) The product for wrinkle surgery is through the biological agent on the wrinkle muscle and its dominating nerve paralysis effect to achieve the purpose of treatment. This treatment does not require a recovery period, just a few minutes to go home directly or go to work. No trauma, no need to rest, does not affect the work. The effect is exact and immediate.
Effect of Botulinum Toxin Filling
Effect
The curative effect usually begins to appear 48 to 72 hours after the injection, and the facial wrinkles become shallow and flat, and the skin becomes smooth. However, due to its mechanism of action, the duration of treatment is usually 3 to 6 months, with an average of 4 months, and a very small number can be extended to 10 months or even a year.
To maintain efficacy, repeat injections should be repeated around 6 months to reduce antibody production. After 2 to 3 consecutive injections, the effect of each injection can last for 6 to 9 months, or even longer. This change process should clearly inform the subject to obtain the cooperation, which is conducive to enhancing the curative effect.
A :We welcome small quantity for testing. MOQ is only one piece!
Yes!
Normally 2 days after receiving your payment, but it can be negotiated based on order quantity. Hope you could understand!
Two years!
We have 12-year experience. We have strictly quality control system in our production process. We have 4 times inspection for each finished product before package.
Botulinum Toxin Type A is widely used in aesthetic medicine to temporarily reduce the appearance of dynamic wrinkles caused by repeated muscle movement. Healthcare professionals may also use it for various therapeutic indications according to local regulatory approvals.
The product temporarily decreases the activity of selected muscles by blocking nerve signals responsible for muscle contraction. As muscle movement is reduced, expression lines gradually become less visible.
Initial improvement is commonly observed within several days after treatment, while full clinical results typically develop within one to two weeks. Individual response may vary.
Treatment effects are temporary. The duration varies among individuals and depends on factors such as treatment area, muscle activity, dosage, and individual metabolism.
Botulinum Toxin Type A should only be administered by qualified healthcare professionals with appropriate training in facial anatomy, injection techniques, and patient assessment.
Unopened vials are generally stored under refrigerated conditions between 2°C and 8°C. Storage and handling should always follow the manufacturer's instructions.
Many formulations are provided as a freeze-dried powder that requires reconstitution before administration. Product presentation may vary depending on the manufacturer.
Depending on the product specification, Botulinum Toxin Type A may be supplied in different unit presentations, such as 100 Units or 200 Units, to support various clinical applications.
Botulinum Toxin Type A should be administered only by appropriately trained healthcare professionals who are familiar with facial anatomy, injection techniques, and patient assessment.
Before treatment, practitioners should evaluate the patient's medical history, treatment goals, muscle activity, and facial balance to determine an appropriate treatment approach. Individual dosage and injection sites vary according to clinical indication and practitioner judgment.
